Who are you?
Julia Bolz is a women’s rights activist providing social guidance to countries in the Middle East, Africa, Central America, and Central Asia. She founded the Journey with an Afghan School program after 9/11 to help bridge the cultural divide between the U.S. and Afghanistan particularly by increasing the educational opportunities afforded to young women. Before joining the grassroots movement for gender equality, she worked at one of Seattle’s most prestigious law firms, Ryan, Swanson & Cleveland. She received Seattle’s Tom C. Wales Citizenship Award for her combined humanitarian efforts. Bolz graduated from Smith College.
Julia Bolz: Well I grew up in Madison, Wisconsin. And one of the things about Madison is it’s about as stable as it can possibly be here in the United States. But one of the things about Madison is that “international” tends to be Iowa. And when I decided I was interested in practicing internationally, I ended up having to move away from Madison to go to one of the various coasts. But what Madison gave me was a greater grounding and a stability that allows me to have the confidence to move on to other parts of the world.My family was a great influence. My mother and father were involved with lots of activities – volunteer activities in the community, as were my grandparents. And they really showed me that serving the community was an extremely important value.
Question: What did you think you'd be doing professionally when you grew up?
Julia Bolz: I had many ambitions. I first thought I would become a doctor. And in fact I applied to medical school. I subsequently have been working as a lawyer, and here I am serving almost as a public speaker and advocate for kids.
The ability to speak clearly, succinctly, and powerfully is easier than you think
The ability to communicate effectively can make or break a person's assessment of your intelligence, competence, and authenticity.
Antimicrobial resistance is growing worldwide, rendering many "work horse" medicines ineffective. Without intervention, drug-resistant pathogens could lead to millions of deaths by 2050. Thankfully, companies like Pfizer are taking action.
- Antimicrobial-resistant pathogens are one of the largest threats to global health today.
- As we get older, our immune systems age, increasing our risk of life threatening infections. Without reliable antibiotics, life expectancy could decline for the first time in modern history.
- If antibiotics become ineffective, common infections could result in hospitalization or even death. Life-saving interventions like cancer treatments and organ transplantation would become more difficult, more often resulting in death. Routine procedures would become hard to perform.
- Without intervention, resistant pathogens could result in 10 million annual deaths by 2050.
- By taking a multi-faceted approach—inclusive of adherence to good stewardship, surveillance and responsible manufacturing practices, as well as an emphasis on prevention and treatment—companies like Pfizer are fighting to help curb the spread.
The climate change we're witnessing is more dramatic than we might think.
A lazy buzz phrase – 'Is this the new normal?' – has been doing the rounds as extreme climate events have been piling up over the past year. To which the riposte should be: it's worse than that – we're on the road to even more frequent, more extreme events than we saw this year.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.